Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease

28Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A wide variety of adverse effects of methimazole (MMI) have been reported. Here we report a new MMI-induced disorder, acute pancreatitis and parotitis. Three weeks after a woman started MMI treatment for Graves' disease, she developed a high fever, painful parotid swelling and dull pain in the upper abdomen with elevation of the serum levels of salivary and pancreatic enzymes. These abnormalities disappeared soon after the withdrawal of MMI. However, the same abnormalities were rapidly provoked when MMI was reintroduced. Marked increases in the leucocyte count and CRP were also observed during these episodes. The possible mechanisms of MMI-induced pancreatitis/parotitis are discussed.

Cite

CITATION STYLE

APA

Taguchi, M., Yokota, M., Koyano, H., Endo, Y., & Ozawa, Y. (1999). Acute pancreatitis and parotitis induced by methimazole in a patient with Graves’ disease. Clinical Endocrinology, 51(5), 667–670. https://doi.org/10.1046/j.1365-2265.1999.00888.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free